NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.13% | 20.60% | 17.58% | 15.55% | 11.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.13% | 20.60% | 17.58% | 15.55% | 11.35% |
| Cost of Revenue | 13.67% | 20.88% | 17.58% | 15.24% | 11.27% |
| Gross Profit | 10.84% | 19.39% | 17.60% | 16.88% | 11.65% |
| SG&A Expenses | 11.67% | 19.25% | 18.68% | 13.59% | 8.73% |
| Depreciation & Amortization | -2.83% | -2.58% | -2.24% | -7.99% | -9.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.89% | 19.91% | 17.09% | 14.19% | 10.16% |
| Operating Income | 22.41% | 51.53% | 42.17% | 99.05% | 93.05% |
| Income Before Tax | 923.20% | 458.88% | 83.13% | 135.64% | -144.03% |
| Income Tax Expenses | -291.52% | 10.37% | 64.19% | 162.61% | 45.56% |
| Earnings from Continuing Operations | 441.07% | 165.64% | 18.99% | 64.37% | -8,146.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.07% | 2.98% | -22.71% | -59.79% | -283.90% |
| Net Income | 270.77% | 101.89% | 5.12% | 38.44% | -952.21% |
| EBIT | 22.41% | 51.53% | 42.17% | 99.05% | 93.05% |
| EBITDA | 10.00% | 22.17% | 16.65% | 33.39% | 26.50% |
| EPS Basic | 271.29% | 102.08% | 5.26% | 38.39% | -910.00% |
| Normalized Basic EPS | 121.43% | 646.15% | 783.33% | 781.82% | 566.67% |
| EPS Diluted | 221.83% | 100.74% | 21.43% | 43.31% | -317.65% |
| Normalized Diluted EPS | 117.50% | 615.38% | 750.00% | 763.64% | 544.44% |
| Average Basic Shares Outstanding | -0.14% | 0.09% | 0.02% | 0.15% | 0.19% |
| Average Diluted Shares Outstanding | 2.59% | 2.32% | 1.69% | 1.82% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |